CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study
Crossref DOI link: https://doi.org/10.1007/s13365-017-0600-6
Published Online: 2017-12-26
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barber, T. J. http://orcid.org/0000-0003-1914-4891
Imaz, A.
Boffito, M.
Niubó, J.
Pozniak, A.
Fortuny, R.
Alonso, J.
Davies, N.
Mandalia, S.
Podzamczer, D.
Gazzard, B.
Funding for this research was provided by:
ViiV Healthcare
License valid from 2017-12-26